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Exercise Training in Patients
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Preserved Ejection Fraction
Findings Awaiting Discovery*
Steven J. Keteyian, PHD
Detroit, Michigan
Since the seminal work by Coats et al. (1) that investigated
the effects of exercise training in patients with heart failure
with reduced ejection fraction (HFREF), a large body of
clinical research has been reported that includes dozens of
single-site randomized trials, numerous meta-analyses and
review articles, and 1 multicenter randomized trial. These
studies followed a logical progression from initially investi-
gating the feasibility of exercise training and its impact on
exercise tolerance to better understanding how regular exer-
cise helps to mitigate the abnormal pathophysiology of heart
failure and its inﬂuence on clinical outcomes (2). Clearly, the
last 20 years has proven to be fertile and rewarding ground for
clinical investigators interested in exercise training, such that
regular exercise is now an evidence-based recommendation in
the care of patients with stable HFREF (3).
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The same cannot be said for exercise in patients with heart
failure with preserved ejection fraction (HFPEF). In fact,
there have been far fewer single-site randomized trials, meta-
analyses, and multicenter randomized trials that investigated
the effects of exercise training in these patients. This paucity
of exercise-related research is unfortunate, given that ap-
proximately 50% of the patients with heart failure have
HFPEF and these same patients demonstrate a degree of
exercise intolerance, impaired quality of life, mortality risk,
and a rehospitalization rate that mirrors or exceeds that of
patients with HFREF (4–6).
In this issue of the Journal, the trial by Kitzman et al. (7),
which investigated the effects of regular exercise on exercise
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greater understanding of the basic physiology that impacts
improving exercise performance in HFPEF. Although there
are some similarities in the symptoms and the pathophysi-
ology of HFREF and HFPEF, Kitzman et al. (7) illuminate
a signiﬁcant difference relative to the effect of exercise
training on peripheral vascular function. Clearly, one can not
simply assume that all of the favorable physiologic adapta-
tions now ascribed to exercise training in patients with
HFREF also occur in patients with HFPEF.
Using a controlled design and appropriate eligibility
criteria, this study randomized 63 elderly patients with
HFPEF (w75% female) to 16 weeks of supervised group
exercise training versus no exercise attention control. Exer-
cise training duration was progressively increased to 40 min
per session and included track walking and leg and arm cycle
ergometry. Observed ﬁndings included 88% attendance to
prescribed exercise sessions, and 86% of all patients com-
pleted testing at both baseline and 16-week follow-up.
Change in brachial artery ﬂow-mediated dilation (FMD),
which was the primary outcome for the study, was not
different between study groups at week 8 or 16. Among
exercise-trained subjects (vs. control) both quality-of-life
scores and exercise capacity (i.e., peak oxygen uptake,
6-min walk distance, or exercise duration) were improved.
The previous observations raise important issues worthy
of further discussion. First, the absence of any change in
brachial artery FMD differs from what is often reported
for exercise training in patients with HFREF (2). This
difference between the 2 forms of heart failure may be due
to differences in patient characteristics, differences in the
mechanism(s) responsible for the abnormality in cardiac
function, the investigator’s decision to exclude patients with
known vascular disease, or the possibility that the marked
disruption of endothelial function is simply an abnormality
that is unique to the pathophysiology of patients with
HFREF (8). The latter suggests that endothelial dysfunction
is neither a cause nor a consequence of HFPEF and there-
fore, not associated with the disease-related exercise intol-
erance. This may explain why some therapies shown to be
effective in treating patients with HFREF are yet to be
proven effective in patients with HFPEF.
Second, Kitzman et al. (7) suggest that their observed
13% increase in peak oxygen uptake among patients with
HFPEF, which is similar to the magnitude of increase re-
ported in patients with HFREF (2), was mostly due to
exercise training induced improvements in the function (e.g.,
capillary density, mitochondrial density, oxidative enzyme
activity) of the metabolically active skeletal muscles. They
base their premise on both the absence of any observed
modulation of vascular function in their recent study and
prior trials from their laboratory (9) and another group of
investigators (10) that showed no exercise training-related
change in peak cardiac output. Although their “peripheral
premise” is likely correct, such discussion calls for future
trials that include evoked measures of skeletal muscle
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of exercise training.
Before closing, I wish to introduce 2 additional topics into
the discussion that stem from this paper. First, likemost of the
other single-site trials conducted to date that involve patients
with eitherHFREF orHFPEF, compliance to exercise in this
trial by Kitzman et al. (7) was excellent at 88% of all prescribed
sessions. However, this level of adherence is somewhat
contrary to what is sometimes observed in large randomized
controlled trials that involve maintenance of regular exercise
in patients with cardiovascular disease. In the National
Exercise and Heart Disease Project that was completed more
than 30 years ago, patients suffering a myocardial infarction
who were randomized to exercise training (vs. nonexercise
control) demonstrated anw47% compliance rate to exercise
at 1 year (11). More recently, the HF-ACTION (Heart
Failure–A Controlled Trial Investigating Outcomes of
Exercise Training) trial showed a compliance rate to the
prescribed amount of exercise to be w40% at 1 year (12).
Taken in sum, the previous begs the larger question of what
factors are altered when investigators deploy adherence
strategies that are used successfully in single-site trials in larger
multisite trials. Why are higher levels of adherence not
maintained? Is it the many comorbidities that accompany
heart failure proper, the less rigorous methods for study
oversight and patient screening that sometimes accompanies
multisite trials, or is it a loosening of the eligibility criteria that
may occur to help ensure the generalizability of trial ﬁndings?
Clearly, to better evaluate the impact of exercise training in the
clinical care of patients with cardiovascular diseases, more
research-derived information is needed that speciﬁcally
targets improved exercise adherence in multisite trials.
A ﬁnal point worth mentioning pertains to the need to
formally revisit insurance reimbursement policies for exercise
training among Medicare beneﬁciaries with heart failure. In
2005 the Centers for Medicare and Medicaid Services
(CMS) reviewed this issue and subsequently denied reim-
bursement for cardiac rehabilitation for patients with heart
failure, despite a level of evidence at that time that exceeded
the level of evidence used by Medicare in its decision to
cover patients with percutaneous coronary intervention,
cardiac transplant and heart valve replacement/repair. Some
7 years later and with an even greater body of evidence
supporting the beneﬁts of exercise training in the care of
patients with heart failure, the timing for another formal
review by CMS is long overdue. Should CMS decide to
cover cardiac rehabilitation for patients with heart failure but
consider limiting such coverage to only those patients with
HFREF, it will miss an opportunity to provide beneﬁt to the
larger body of patients with heart failure, both HFREF and
HFPEF. Speciﬁcally, the evidence supporting the use of
exercise training to improve quality of life and exercise
capacity in patients with HFPEF is now equal to or exceeds
the level of evidence in 2006 that led to the coverage for
cardiac transplant, percutaneous coronary intervention and
valve replacement/repair.This paper by Kitzman et al. (7) is important because it
shows that exercise training improves exercise tolerance in
older patients with HFPEF and that such improvement is
likely independent of changes in FMD. It forces future
research into the study of metabolism within the more active
skeletal muscles that are involved with exercise. This paper
also stimulates us to gather more knowledge about how
exercise adherence can be sustained when trials are scaled up
from a single-site to multisite setting and pushes further the
need for a revised policy from CMS that provides coverage
for cardiac rehabilitation care for patients with heart failure.
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